News
BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...
Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in intensive care unit (ICU), ...
The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing ...
1d
Sportschosun on MSNThe number of patients with chronic kidney disease due to aging ↑…Beringer Ingelheim Korea conducts a patient immersive experience program for executives and employeesThe number of patients with chronic kidney disease is increasing with aging. According to the Health Insurance Review and Assessment Service, the number of patients with chronic kidney disease surged ...
Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.
Clinical trials suggesting that hemodiafiltration offers a survival benefit over hemodialysis have largely been conducted among the prevalent dialysis population, so investigators examined an incident ...
Researchers have identified in a new study that patients with renal failure undergoing chronic kidney replacement therapy ...
Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective ...
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 inhibitor use, according to data presented at the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results